Concepts of hemopoietic cell amplification. Synergy, redundancy and pleiotropy of cytokines affecting the regulation of erythropoiesis

Leukemia and Lymphoma

Volumn 22, Issue 5-6, 1996, Pages 385-394

  De Haan, Gerald ^a   Dontje, Bert ^b   Nijhof, Willem ^b,c  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Amplification; EPO; Erythropoiesis; Hemopoiesis; IL 11; SCF

Indexed keywords

CYTOKINE; CYTOTOXIC AGENT; ERYTHROPOIETIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 1; INTERLEUKIN 11; STEM CELL FACTOR;

APOPTOSIS; BLAST CELL; BLOOD TOXICITY; BONE MARROW; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMING UNIT E; COLONY FORMING UNIT GM; DRUG EFFECT; ERYTHROCYTE; ERYTHROPOIESIS; HEMATOPOIESIS; HEMATOPOIETIC CELL; HUMAN; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SARCOMA; SPLEEN; STEM CELL;

EID: 0029848391     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609054776     Document Type: Review

References (64)

1. Quesniaux, V. F., Graham, G. J., Pragnell, I., Donaldson, D., Wolpe, S. D., Iscove, N. N., Fagg, B. (1993) Use of 5-fluorouracil to analyze the effect of macrophage inflammatory protein-1 alpha on long-term reconstituting stem cells in vivo. Blood, 81, 1497.
2. Down, J. D., Ploemacher, R. E. (1993) Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs. Exp. Hematol., 21, 913.
3. Lemer, C., Harrison, D. E. (1990) 5-Fluorouracil spares hemopoietic stem cells responsible for long-term repopulation. Exp. Hematol., 18, 114.
4. Hodgson, G. S., Bradley, T. R. (1979) Properties of haematopoietic stem cells surviving 5-fluorouracil treatment: evidence for a preCFU-S cell? Nature, 281, 381.
5. Van Zant, G. (1984) Studies of hematopoietic stem cells spared by 5-fluorouracil. J. Exp. Med., 159, 679.
6. Harrison, D. E., Lerner, C. P. (1991) Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood, 78, 1237.
7. de Haan, G., Dontje, B., Engel, C., Loeffler, M., Nijhof, W. (1995) Growth factor-induced in vivo expansion of primitive cells protects against lethal dose of 5-fluorouracil. Exp. Hematol., 23, 872 (abstract).
8. Fairbairn, L. J., Cowling, G. J., Reipeft, B. M., Dexter, T. M. (1993) Suppression of apoptosis allows differentiation and development of a multipotent hematopoietic cell line in the absence of added growth factors. Cell, 74, 823.
9. Ogawa, M. (1993) Differentiation and proliferation of hematopoietic stem cells. Blood, 81, 2844.
10. Leary, A. G., Zeng, H. Q., Clark, S. C., Ogawa, M. (1992) Growth factor requirements for survival in GO and entry into the cell cycle of primitive human hemopoietic progenitors. Proc. Natl. Acad. Sci. U. S. A., 89, 4013.
11. Tsuji, K., Zsebo, K. M., Ogawa, M. (1991) Enhancement of murine blast cell colony formation in culture by recombinant rat stem cell factor, ligand for c-kit. Blood, 78, 1223.
12. Tsuji, K., Lyman, S. D., Sudo, T., Clark, S. C., Ogawa, M. (1992) Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood, 79, 2855.
13. Ploemacher, R. E., van der Sluijs, J. P., van Beurden, C. A., Baert, M. R., Chan, P. L. (1991) Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. Blood, 78, 2527.
14. Neta, R., Douches, S., Oppenheim, J. J. (1986) Interleukin 1 is a radioprotector. J. Immunol., 136, 2483.
15. Zsebo, K. M., Smith, K. A., Hartley, C. A., Greenblatt, M., Cooke, K., Rich, W., Mcniece, I. K. (1992) Radioprotection of mice by recombinant rat stem cell factor. Proc. Natl. Acad. Sci. U. S. A., 89, 9464.
16. de Haan, G., Engel, C., Dontje, B., Loeffler, M., Nijhof, W. (1995) Hemotoxicity by prolonged etoposide administration to mice can be prevented by simultaneous growth factor therapy. Cancer Res., 55, 324.
17. Nijhof, W., de Haan, G., Dontje, B., Engel, C., Loeffler, M. (1995) Maintenance of normal hemopoietic cell production during simultaneous administration of cytotoxic drugs and hemopoietic growth factors to mice. Exp. Hematol., 23, 871 (abstract).
18. Molineux, G., Migdalska, A., Haley, J., Evans, G. S., Dexter, T. M. (1994) Total marrow failure induced by pegylated stem-cell factor administered before 5-fluorouracil. Blood, 83, 3491.
19. Metcalf, D. (1980) Clonal analysis of proliferation and differentiation of paired daughter cells: action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors. Proc. Natl. Acad. Sci. U. S. A., 77, 5327.
20. Tanaka, R., Katayama, N., Ohishi, K., Mahmud, N., Itoh, R., Tanaka, Y., Komada, Y., Minami, N., Sakurai, M., Shirakawa, S., Shiku, H. (1995) Accelerated cell-cycling of hematopoietic progenitor cells by growth factors. Blood, 86, 73.
21. Muta, K., Krantz, S. B., Bondurant, M. C., Dai, C. H. (1995) Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation. Blood, 86, 572.
22. Broxmeyer, H. E., Cooper, S., Williams, D. E., Hangoc, G., Gutterman, J. U., Vadhan-Raj, S. (1988) Growth characteristics of marrow hematopoietic progenitor/precursor cells from patients on a phase I clinical trial with purified recombinant human granulocyte-macrophage colony-stimulating factor. Exp. Hematol., 16, 594.
23. Vadhan-Raj, S., Broxmeyer, H. E., Hittelman, W. N., Papadopoulos, N. E., Chawla, S. P., Fenoglio, C., Cooper, S., Buescher, E. S., Frenck, R. W., Jr., Holian, A. et al. (1992) Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level. J. Clin. Oncol., 10, 1266.
24. Broxmeyer, H. E., Benninger, L., Patel, S. R., Benjamin, R. S., Vadhan Raj, S. (1994) Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocyte-macrophage colony-stimulating factor. Exp. Hematol., 22, 100.
25. Hangoc, G., Yin, T., Cooper, S., Schendel, P., Yang, Y. C., Broxmeyer, H. E. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood, 81, 965.
26. Lord, B. I., Bronchud, M. H., Owens, S., Chang, J., Howell, A., Souza, L., Dexter, T. M. (1989) The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc. Natl. Acad. Sci. U.S.A., 86, 9499.
27. Lord, B. I., Molineux, G., Pojda, Z., Souza, L. M., Mermod, J. J., Dexter, T. M. (1991) Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood, 77, 2154.
28. Lord, B. I., Testa, N. G., Bretti, S., Chang, J., Demuynck, H., Coutinho, L., Decampos, E., Fitzsimmons, L., Scarffe, J. H. (1994) Haemopoietic progenitor and myeloid cell kinetics in humans treated with interleukin-3 and granulocyte macrophage colony-stimulating factor in combination. Int. J. Cancer, 59, 483.
29. Kerr, J. F., Wyllie, A. H., Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 26, 239.
30. Koury, M. J. (1992) Programmed cell death (apoptosis) in hematopoiesis. Exp. Hematol., 20, 391.
31. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., Tlsty, T. D. (1992) Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70, 923.
32. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., Wahl, G. M. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937.
33. Koury, M. J., Bondurant, M. C. (1990) Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science, 248, 378.
34. Williams, G. T., Smith, C. A., Spooncer, E., Dexter, T. M., Taylor, D. R. (1990) Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis. Nature, 343, 76.
35. Metcalf, D., Merchav, S. (1982) Effects of GM-CSF deprivation on precursors of granulocytes and macrophages. J. Cell. Physiol., 112, 411.
36. Spooncer, E., Heyworth, C. M., Dunn, A., Dexter, T. M. (1986) Selfrenewal and differentiation of interleukin-3-dependent multipotent stem cells are modulated by stromal cells and serum factors. Differentiation, 31, 111.
37. Whetton, A. D., Dexter, T. M. (1983) Effect of haematopoietic cell growth factor on intracellular ATP levels. Nature, 303, 629.
38. Roberts, R., Gallagher, J., Spooncer, E., Allen, T. D., Bloomfield, F., Dexter, T. M. (1988) Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature, 332, 376.
39. Williams, D. E., Broxmeyer, H. E. (1988) Interleukin-1 alpha enhances the in vitro survival of purified murine granulocyte-macrophage progenitor cells in the absence of colony-stimulating factors. Blood, 72, 1608.
40. Nijhof, W., Wierenga, P. K., Pietens, J., Bloem, R. (1984) Cell kinetic behaviour of a synchronized population of erythroid precursor cells in vitro. Cell. Tissue Kinet., 17, 629.
41. Nijhof, W., Dehaan, G., Pietens, J., Dontje, B. (1995) Mechanistic options of erythropoietin-stimulated erythropoiesis. Exp. Hematol., 23, 369.
42. Lotem, J., Sachs, L. (1992) Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor beta 1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood, 80, 1750.
43. Rodriguez-Tarduchy, G., Collins, M., Lopez-Rivas, A. (1990) Regulation of apoptosis in interleukin-3-dependent hemopoietic cells by interleukin-3 and calcium ionophores. EMBO J, 9, 2997.
44. Vaux, D. L., Cory, S., Adams, J. M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature, 335, 440.
45. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D., Korsmeyer, S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature, 348, 334.
46. Nunez, G., London, L., Hockenbery, D., Alexander, M., Mckearn, J. P., Korsmeyer, S. J. (1990) Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol., 144, 3602.
47. Lotem, J., Sachs, L. (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood, 82, 1092.
48. Bodine, D. (1995) Mobilization of peripheral blood 'stem' cells: Where there is smoke, is there fire? Exp. Hematol., 23, 293.
49. de Haan, G., Dontje, B., Nijhof, W., Loeffler, M. (1995) Effects of continuous stem cell factor administration on normal and erythropoietin-stimulated murine hemopoiesis: Experimental results and model analysis. Stem Cells, 13, 65.
50. Nijhof, W., Goris, H., Dontje, B., Dresz, J., Loeffler, M. (1993) Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment. Exp. Hematol., 21, 496.
51. de Haan, G., Loeffler, M., Nijhof, W. (1992) Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia. Exp. Hematol., 20, 600.
52. Goris, H., Bungart, B., Loeffler, M., Schmitz, S., Nijhof, W. (1990) Migration of stem cells and progenitors between marrow and spleen following thiamphenicol treatment of mice. Exp. Hematol., 18, 400.
53. de Haan, G., Engel, C., Dontje, B., Nijhof, W., Loeffler, M. (1994) Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: In vivo interactions and dose-response surfaces. Blood, 84, 4157.
54. de Haan, G., Dontje, B., Engel, C., Loeffler, M., Nijhof, W. (1995) In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis. Br. J. Haematol., 90, 783.
55. Muta, K., Krantz, S. B., Bondurant, M. C., Wickrema, A. (1994) Distinct roles of erythropoietin, insulin-like growth factor I, and stem cell factor in the development of erythroid progenitor cells. J. Clin. Invest., 94, 34.
56. Quesniaux, V. F., Clark, S. C., Turner, K., Fagg, B. (1992) Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood, 80, 1218.
57. Scheding, S., Loeffler, M., Anselstetter, V., Wichmann, H. E. (1992) A mathematical approach to benzo[a]pyrene-induced hematotoxicity. Arch. Toxicol., 66, 546.
58. Scheding, S., Loeffler, M., Schmitz, S., Seidel, H. J., Wichmann, H. E. (1992) Hematotoxic effects of benzene analyzed by mathematical modeling. Toxicology, 72, 265.
59. Loeffler, M., Pantel, K. (1990) A mathematical model of erythropoiesis suggests an altered plasma volume control as cause for anemia in aged mice. Exp. Gerontol., 25 483.
60. Pantel, K., Loeffler, M., Bungart, B., Wichmann, H. E. (1990) A mathematical model of erythropoiesis in mice and rats. Part 4: Differences between bone marrow and spleen. Cell Tissue Kinet., 23, 283.
61. Wulff, H., Wichmann, H. E., Pantel, K., Loeffler, M. (1989) A mathematical model of erythropoiesis in mice and rats. Part 3: Suppressed erythropoiesis. Cell Tissue Kinet., 22, 51.
62. Wichmann, H. E., Loeffler, M., Pantel, K., Wulff, H. (1989) A mathematical model of erythropoiesis in mice and rats. Part 2: Stimulated erythropoiesis. Cell Tissue Kinet., 22, 31.
63. Loeffler, M., Pantel, K., Wulff, H., Wichmann, H. E. (1989) A mathematical model of erythropoiesis in mice and rats. Part 1: Structure of the model. Cell Tissue Kinet., 22, 13.
64. de Haan, G., Dontje, B., Engel, C., Loeffler, M., Nijhof, W. (1995) The kinetics of murine hemopoietic stem cells in vivo in response to prolonged increased mature blood cell production, induced by granulocyte colony-stimulating factor. Blood, 86, 2986.